2012
DOI: 10.1073/pnas.1212245109
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms modulating immune clearance during human cytomegalovirus latency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 25 publications
0
5
0
Order By: Relevance
“…Results of these studies have suggested that the blood contains a large pool of CMV-specific circulating Tem cells, guarding against potential systemic reactivation, whereas both the site of primary entry (lungs) and extensive initial replication and shedding (salivary gland) contain Trm cells standing guard against potential reinfection (lung) and/or local reactivation (lung and salivary gland). CMV is believed to infect many cells, but to establish latency only in very few [7,60,61]. In that context and in the context of an early and lifelong CMV infection and immunity, we know very little about CMV-specific CD8 T cell immunity and control in other tissues.…”
Section: Discussionmentioning
confidence: 99%
“…Results of these studies have suggested that the blood contains a large pool of CMV-specific circulating Tem cells, guarding against potential systemic reactivation, whereas both the site of primary entry (lungs) and extensive initial replication and shedding (salivary gland) contain Trm cells standing guard against potential reinfection (lung) and/or local reactivation (lung and salivary gland). CMV is believed to infect many cells, but to establish latency only in very few [7,60,61]. In that context and in the context of an early and lifelong CMV infection and immunity, we know very little about CMV-specific CD8 T cell immunity and control in other tissues.…”
Section: Discussionmentioning
confidence: 99%
“…A good model to study antigen‐specific CD4 + memory responses is CMV infection. The beta‐herpes virus CMV replicates systemically after establishing infection via the mucosa, targeting various epithelial, endothelial and myeloid cells, maintaining long‐term residence in precursors of macrophages and dendritic cells 10 . Once these cells become terminally differentiated APCs, they support re‐activation and persistent viral replication and this leads to T‐cell activation.…”
Section: Discussionmentioning
confidence: 99%
“…Healthy individuals mount a broad and sustained antiviral T‐cell response, sometimes up to 10% of total CD4 + and CD8 + T cells can be CMV specific. Despite this extraordinary antiviral response, CMV is never completely cleared, and CMV infection of individuals whose immune system is compromised (such as HIV/AIDS patients) can be life threatening or can cause significant morbidity through reactivation 10 , 11 …”
Section: Discussionmentioning
confidence: 99%
“…The basic mechanisms have been widely investigated and involve complex immunomodulatory processes that ultimately lead to loss of graft function ( 38 41 ). In particular, both CMV and EBV contain large DNA genomes that produce various decoy molecules that act at both the intracellular and extracellular levels and interfere with several stages and critical points of immune regulation ( 42 45 ). In the present study, several statistical approaches were used to explore the association between CMV and EBV infections and AMR risk among HTxs.…”
Section: Discussionmentioning
confidence: 99%